Cargando…
Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation
BACKGROUND: Metformin, an oral biguanide traditionally used for the treatment of type 2 diabetes, is widely used for the management of polycystic ovary syndrome (PCOS)-related anovulation. Because of the significant prevalence of insulin resistance and glucose intolerance in PCOS patients, and their...
Autores principales: | Sabatini, Mary E, Guo, Lankai, Lynch, Maureen P, Doyle, Joseph O, Lee, HoJoon, Rueda, Bo R, Styer, Aaron K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121715/ https://www.ncbi.nlm.nih.gov/pubmed/21605417 http://dx.doi.org/10.1186/1757-2215-4-8 |
Ejemplares similares
-
Adverse Effect of Superovulation Treatment on Maturation, Function and Ultrastructural Integrity of Murine Oocytes
por: Lee, Myungook, et al.
Publicado: (2017) -
Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011) -
Effect of Superovulation Treatment on Oocyte’s DNA Methylation
por: Lopes, Jordana S., et al.
Publicado: (2022) -
Genome-wide assessment of DNA methylation in mouse oocytes reveals effects associated with in vitro growth, superovulation, and sexual maturity
por: Saenz-de-Juano, Maria Desemparats, et al.
Publicado: (2019) -
The proteome, not the transcriptome, predicts that oocyte superovulation affects embryonic phenotypes in mice
por: Taher, Leila, et al.
Publicado: (2021)